spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 6 Dec 2008
Rituxan in Combination with Chemotherapy Improves Progression-Free Survival in Difficult-to-Treat Form of Blood Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Dec 2008
FDA Advisory Committee Recommends Approval of Bausch & Lomb Besifloxacin Anti-Infective Eye Drop
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 5 Dec 2008
Avila Therapeutics Appoints Daniel S. Lynch as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2008
Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2008
Osiris Receives Approval for Prochymal Expanded Access Program in Canada
Biopharmaceuticals Regenerative Medicine Regulatory
 HSMN NewsFeed - 4 Dec 2008
Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc to Acquire U.S. Rights to Elestrin (TM)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 4 Dec 2008
NovaRx Appoints Industry Veteran as President and COO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2008
European Commission Approval of New Indication for Roche's Pegasys(R) (peginterferon alfa-2a) Offers Hepatitis C Patients a Second Chance for a Cure
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Dec 2008
Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab)
Biopharmaceuticals
 HSMN NewsFeed - 3 Dec 2008
AstraZeneca Appoints Graham Baker Vice President and Chief Financial Officer for North America
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Dec 2008
Catalyst Biosciences Raises $40 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Dec 2008
AVI BioPharma Files IND for Clinical Trial of Marburg Virus Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Dec 2008
Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Dec 2008
Caroline Loewy Joins Corcept as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2008
Cubist Names Santosh J. Vetticaden as SVP, Clinical Development and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2008
TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia
Biopharmaceuticals
 HSMN NewsFeed - 2 Dec 2008
BrainCells Inc. Appoints David E. Thompson to Its Board of Directors
Regenerative Medicine Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2008
Vion Pharmaceuticals Adds Tanya Lewis to Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2008
Targeted Genetics Realigns Product Development Priorities and Implements Cost Reduction Measures
Biopharmaceuticals
 HSMN NewsFeed - 2 Dec 2008
Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2008
Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity
Biopharmaceuticals Generics Oncology
 HSMN NewsFeed - 1 Dec 2008
Cambridge Laboratories Announces Launch of XENAZINE(R) (Tetrabenazine) in the US
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 Dec 2008
FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Nov 2008
Attorney Thomas Equels Elected to Hemispherx Biopharma Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Nov 2008
Hemispherx Biopharma Introduces Expense Reduction Program
Biopharmaceuticals
 HSMN NewsFeed - 28 Nov 2008
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Biopharmaceuticals
 HSMN NewsFeed - 27 Nov 2008
European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1
Biopharmaceuticals HIV/AIDS Regulatory
 HSMN NewsFeed - 27 Nov 2008
Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Nov 2008
Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 26 Nov 2008
Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Nov 2008
Tarceva(R) (erlotinib) Endorsed by the U.K.'s National Institute for Health and Clinical Excellence for Use in Patients with Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Nov 2008
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
Biopharmaceuticals
 HSMN NewsFeed - 26 Nov 2008
FDA Issues Complete Response Letter for Ceftobiprole for Treatment of Complicated Skin Infections
Biopharmaceuticals
 HSMN NewsFeed - 25 Nov 2008
Watson Enters Into Agreement to Acquire Products Related to Teva's Proposed Acquisition of Barr
Biopharmaceuticals Acquisitions Generics
 HSMN NewsFeed - 25 Nov 2008
Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Nov 2008
Roche signs definitive agreement to acquire Memory Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Nov 2008
Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Nov 2008
Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
Biopharmaceuticals
 HSMN NewsFeed - 24 Nov 2008
Lilly Completes Acquisition of ImClone Systems
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Nov 2008
NCCN Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Nov 2008
David R. King Joins Diasome Pharmaceuticals as Chairman of the Board
Biopharmaceuticals Endocrinology Drug Delivery Personnel
 HSMN NewsFeed - 24 Nov 2008
Biovitrum's and Syntonix's Novel Factor IXFc for Hemophilia B has Received Orphan Drug Designation From the FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Nov 2008
King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Nov 2008
Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
Biopharmaceuticals
 HSMN NewsFeed - 24 Nov 2008
Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Nov 2008
Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival In Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Nov 2008
CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Nov 2008
Lilly Completes Cash Tender Offer for ImClone Systems
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Nov 2008
Zevtera(TM) (ceftobiprole medocaril), the novel anti-MRSA broad-spectrum antibiotic, receives a positive opinion from the CHMP
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Nov 2008
Adimab, Inc. Announces Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Nov 2008
Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Nov 2008
Teva Provides Update on Generic Pulmicort Respules® Launch
Biopharmaceuticals Generics
 HSMN NewsFeed - 19 Nov 2008
GenVec Announces Interim Survival Data in Pivotal Trial of TNFerade in Locally Advanced Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Nov 2008
Impax Sued Based on Anda for Generic Cymbalta(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 18 Nov 2008
AstraZeneca Appoints Rich Fante as President of its U.S. Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Nov 2008
Delcath Systems Granted Orphan-Drug Designations for Cutaneous and Ocular Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Nov 2008
Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 Nov 2008
IDM Pharma Receives Recommendation for Approval of Mifamurtide (MEPACT(R), L-MTP-PE) for the Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma in Europe from the Committee for Medicinal Products for Human Use (CHMP)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Nov 2008
Long-Term TITAN Study Evaluates PREZISTA(R)/ritonavir vs. lopinavir/ritonavir as Part of HIV Combination Therapy in Treatment-Experienced Adults
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 17 Nov 2008
Mylan Receives Tentative FDA Approval for the Generic Version of the Antidepressant Effexor XR(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Nov 2008
Lilly Licenses U.S. Rights for Tadalafil PAH Indication to United Therapeutics
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Nov 2008
FREEDOM-C Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Fails to Meet Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 14 Nov 2008
VALEANT PHARMACEUTICALS ACQUIRES DERMATECH
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 13 Nov 2008
MedImmune Announces Zook as President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2008
Perrigo Acquires Unico Holdings
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Nov 2008
GARDASIL®, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Nov 2008
TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Nov 2008
Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Nov 2008
Accera, Inc. Completes $35 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Nov 2008
TNFerade(TM) Receives FDA Fast Track Designation for Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Nov 2008
Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Nov 2008
Integrated BioPharma, Inc. Announces New Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Nov 2008
Targeted Genetics Board of Directors Names B.G. Susan Robinson as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Nov 2008
AMDL, Inc. Promotes CFO Akio Ariura to Chief Operating Officer and Expands Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2008
PDL BioPharma Appoints John P. McLaughlin to Become President and CEO Upon Completion of Spin-Off of Biotechnology Assets
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2008
MacuSight Appoints Gerald Wroblewski Vice President of Operations
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 6 Nov 2008
FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 5 Nov 2008
AMDL, Inc. Names Douglas MacLellan as Executive Chairman & CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2008
Akesis Pharmaceuticals Appoints Carl LeBel as CEO and Jay Lichter as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2008
SurModics Acquires Drug Delivery Assets of PR Pharmaceuticals
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 4 Nov 2008
Mylan Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra(R) and Launches Immediately
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 4 Nov 2008
Sanvar(R) (Debio 8609) for Esophageal Variceal Bleeding - Debiopharm Submits Response to the FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 4 Nov 2008
OncoMed Pharmaceuticals Completes Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Nov 2008
Biolex Therapeutics Adds Two Drug Development Executives to Accelerate Development of Locteron(R) in Hepatitis C
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2008
Genentech Submits Application to U.S. Food and Drug Administration for Avastin in the Most Aggressive Form of Brain Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Nov 2008
CyDex Pharmaceuticals Hires Vice President, Business Development and Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2008
Covidien and PETNET Solutions Enter Co-Marketing Agreement for Nuclear Medicine Products
Biopharmaceuticals Radiology
 HSMN NewsFeed - 3 Nov 2008
Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Nov 2008
Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Nov 2008
NCCN Updates Guidelines for Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Nov 2008
APRISO(TM) Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Nov 2008
DAIICHI SANKYO Acquires Merck Serono's Cardio-Metabolism Sales Force and Products in Turkey
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 31 Oct 2008
Pfizer's TOVIAZ(TM) (fesoterodine fumarate) Receives FDA Approval for the Treatment of Overactive Bladder
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 31 Oct 2008
Savient Submits Biologics License Application (BLA) for pegloticase
Biopharmaceuticals
 HSMN NewsFeed - 31 Oct 2008
Spectrum Pharmaceuticals Files Supplemental New Drug Application with FDA for FUSILEV(TM) in Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Oct 2008
Alnara Pharmaceuticals, Inc. Secures $20 Million in Series A Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Oct 2008
Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2008
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
Biopharmaceuticals FDA Endocrinology
 HSMN NewsFeed - 29 Oct 2008
EMD Serono and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Oct 2008
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Oct 2008
Biopure Sues National Institutes of Health Official
Biopharmaceuticals
 HSMN NewsFeed - 28 Oct 2008
Infinity Announces the Promotion of Adelene Q. Perkins to President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2008
Gilead Announces Two-Year Clinical Data for Letairis(R) (ambrisentan) for the Treatment of Pulmonary Arterial Hypertension (WHO Group 1)
Biopharmaceuticals
 HSMN NewsFeed - 28 Oct 2008
Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 28 Oct 2008
CoLucid Pharmaceuticals Names Linda Hogan VP of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2008
MDS Pharma Services Takes Novel Steps to Recruit Patients for Alzheimer’s Disease Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Oct 2008
InfaCare Pharmaceutical Corporation Raises $28 Million in Series B Financing to Advance Its Neonatal Pipeline
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Oct 2008
FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Oct 2008
Cipher appoints Vice-President of Portfolio Development and Licensing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2008
One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study
Biopharmaceuticals
 HSMN NewsFeed - 27 Oct 2008
CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
Biopharmaceuticals
 HSMN NewsFeed - 27 Oct 2008
Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 27 Oct 2008
New Study Shows ENBREL(R) (etanercept) Is More Effective than a DMARD in the Treatment of Symptoms of Ankylosing Spondylitis Patients
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2008
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Oct 2008
Cancer Drug Vidaza(R) Receives Positive Opinion from European Regulatory Authority for Treatment of MDS and AML
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Oct 2008
European Medicines Agency (EMEA) Issues Positive Opinion For LUNIVIA(R) (Eszopiclone) Marketing Authorization Application (MAA) In Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Oct 2008
Hospitals, Healthcare Providers to Save with Premier Agreement for Cardiac Ultrasound Contrast Media
Biopharmaceuticals Radiology Group Purchasing
 HSMN NewsFeed - 23 Oct 2008
NitroMed Announces Agreement to Sell BiDil(R) Drug Business to JHP Pharmaceuticals, LLC
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 23 Oct 2008
EPIX Pharmaceuticals Announces Reduction in Force
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2008
OXiGENE, Inc. Names John A. Kollins as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2008
Study Published in New England Journal of Medicine Shows K-ras Gene Mutation Status May Affect Response to ERBITUX(R) Treatment
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Oct 2008
Pfizer Completes Settlement Agreements with State Attorneys General Regarding its NSAID Pain Medications
Biopharmaceuticals
 HSMN NewsFeed - 22 Oct 2008
FDA Approves Astellas' Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Oct 2008
NeurogesX Submits NDA for NGX-4010 Dermal Capsaicin Patch for Treatment of Postherpetic Neuralgia (PHN)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 22 Oct 2008
Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP
Biopharmaceuticals
 HSMN NewsFeed - 22 Oct 2008
Mylan Receives Tentative FDA Approval for First-to-File Generic Version of Blood Pressure Drug Benicar HCT(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Oct 2008
Pfizer Names New Head of Clinical Development and Medical Affairs for Its Oncology Business Unit
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Oct 2008
Sosei Agrees Terms With ASKA for Commercialisation of SOH-075 (NorLevo(R))
Biopharmaceuticals
 HSMN NewsFeed - 21 Oct 2008
ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Oct 2008
GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 21 Oct 2008
Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Oct 2008
Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Oct 2008
Tracon Pharmaceuticals Appoints Bryan Leigh, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Oct 2008
Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 21 Oct 2008
Abbott's HUMIRA(R) (adalimumab) Data Shows Fistula Healing for Up to Three Years in Patients with Moderate to Severe Crohn's Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 21 Oct 2008
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in France
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 20 Oct 2008
Bob Cunard Appointed President of Glades Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Oct 2008
Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Oct 2008
Avidas Pharmaceuticals Launches Vitaphenol(R)
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 20 Oct 2008
High-Dose Zevalin(R) With Tandem Stem Cell Infusion Produces 87 Percent Overall Survival in Relapsed/Refractory or High Risk Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Oct 2008
Genentech Announces Phase III Study of Avastin Plus Chemotherapy in Adjuvant Colon Cancer Will Continue
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Oct 2008
Valeant Pharmaceuticals and GlaxoSmithKline Complete Worldwide Collaboration Agreement for Retigabine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Oct 2008
Pfizer Reaches Agreements in Principle to Resolve Litigation Involving Its NSAID Pain Medications
Biopharmaceuticals Litigation
 HSMN NewsFeed - 17 Oct 2008
CeNeRx BioPharma Completes $15 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Oct 2008
Abraxis BioScience and Specialised Therapeutics Australia Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in Australia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 15 Oct 2008
New Maturation Inhibitor Drugs May Provide Solution to HIV Treatment Conundrum
Biopharmaceuticals Diagnostics HIV/AIDS
 HSMN NewsFeed - 15 Oct 2008
Arbor Pharmaceuticals Launches NEOTIC(tm) – A New Prescription Treatment for the Painful Symptoms of Common Middle Ear Infections
Biopharmaceuticals
 HSMN NewsFeed - 15 Oct 2008
Lilly Launches New FORTEO Delivery Device
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 15 Oct 2008
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in Finland
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 14 Oct 2008
Gerard A. Martino Resigns as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2008
Surface Logix Appoints Keith Dionne as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2008
Par Pharmaceutical Announces Resizing of Generic Unit to Optimize Strong First-to-File Pipeline
Biopharmaceuticals Generics
 HSMN NewsFeed - 14 Oct 2008
Omrix Biopharmaceuticals Receives Approval from European Medicines Agency for Evicel Liquid Fibrin Sealant (Human)
Biopharmaceuticals Wound Care Regulatory
 HSMN NewsFeed - 14 Oct 2008
Dr. Reddy's Wholly-Owned Subsidiary Promius Pharma Launches EPICERAM(R) Skin Barrier Emulsion
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 14 Oct 2008
Promius Pharma, LLC Launches EpiCeram(R) Skin Barrier Emulsion
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 13 Oct 2008
Theron Odlaug, Ph.D. Promoted to Chief Executive Officer at CyDex Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2008
Antares Pharma Appoints Paul K. Wotton, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!